Literature DB >> 17869573

A further evaluation of the cognitive deficits associated with restless legs syndrome (RLS).

Charlene E Gamaldo1, Amy R Benbrook, Richard P Allen, Oluwamurewa Oguntimein, Christopher J Earley.   

Abstract

BACKGROUND AND
PURPOSE: Restless legs syndrome (RLS) is a common sensorimotor disorder that peaks in severity during the night and comes on with rest. As a result, this condition often results in significant chronic sleep loss, especially for those with severe disease. Chronic partial sleep restriction has been associated with conditions such as depression, anxiety, chronic pain, and decline in cognitive function. Furthermore, studies have found that RLS patients suffer from these conditions more than their unaffected peers. Thus, the morbidity rate associated with RLS has often been attributed to the chronic sleep loss that frequently accompanies this condition. However, no study has specifically compared RLS sufferers to otherwise normal sleep-restricted controls in order to assess disease morbidity independent of its sleep deprivation effects. In this study, we compared the cognitive function of RLS patients who were off treatment to sleep-restricted control subjects. SUBJECTS AND METHODS: A novel chronic partial sleep-restriction protocol that utilized a 14-day combined inpatient and outpatient design was implemented in order to test the differences in cognitive functioning between RLS patients and sleep-restricted controls. The brief cognitive battery included instruments assessing general intelligence and global executive function in order to control for baseline cognitive function between the groups, and then the effects of sleep loss were assessed using prefrontal lobe-specific tasks. The final sample consisted of 16 RLS (11 male and 5 female) and 13 sleep-restricted control subjects (7 male and 6 female).
RESULTS: In order to examine the differences in cognitive functioning between sleep-restricted controls and RLS subjects, independent samples t-tests were conducted. RLS subjects performed significantly better on both the Letter Fluency (t=2.13, p<0.05) and Category Fluency (t=2.42, p<0.05) than sleep-restricted controls.
CONCLUSIONS: RLS subjects performed better than the sleep-restricted controls on two tasks that are particularly sensitive to sleep loss. Although previous studies suggest that sleep deprivation may impact the cognitive function of those with RLS, our data suggests that RLS subjects may show a relative degree of sleep loss adaptation. Future investigations that more closely match the sleep loss pattern of RLS subjects to controls are warranted in order to explore these potential traits further.

Entities:  

Mesh:

Year:  2007        PMID: 17869573      PMCID: PMC2532669          DOI: 10.1016/j.sleep.2007.07.014

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  19 in total

1.  Concurrent validity of the Test of Nonverbal Intelligence in Parkinson's disease patients.

Authors:  S Bostantjopoulou; G Kiosseoglou; Z Katsarou; A Alevriadou
Journal:  J Psychol       Date:  2001-03

2.  Cognitive control in the posterior frontolateral cortex: evidence from common activations in task coordination, interference control, and working memory.

Authors:  Jan Derrfuss; Marcel Brass; D Yves von Cramon
Journal:  Neuroimage       Date:  2004-10       Impact factor: 6.556

3.  Validation of the Johns Hopkins restless legs severity scale.

Authors:  R P. Allen; C J. Earley
Journal:  Sleep Med       Date:  2001-05       Impact factor: 3.492

4.  Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome.

Authors:  Magdolna Hornyak; Marta Kopasz; Mathias Berger; Dieter Riemann; Ulrich Voderholzer
Journal:  J Clin Psychiatry       Date:  2005-09       Impact factor: 4.384

5.  Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset.

Authors: 
Journal:  Sleep Med       Date:  2000-02-01       Impact factor: 3.492

6.  Predictors of health-related quality of life in sufferers with restless legs syndrome: a multi-national study.

Authors:  Louise McCrink; Richard P Allen; Sorrel Wolowacz; Beth Sherrill; Mark Connolly; Jeff Kirsch
Journal:  Sleep Med       Date:  2006-10-04       Impact factor: 3.492

7.  Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night.

Authors:  D F Dinges; F Pack; K Williams; K A Gillen; J W Powell; G E Ott; C Aptowicz; A I Pack
Journal:  Sleep       Date:  1997-04       Impact factor: 5.849

8.  Cognitive deficits associated with restless legs syndrome (RLS).

Authors:  Virginia E Pearson; Richard P Allen; Terry Dean; Charlene E Gamaldo; Suzanne R Lesage; Christopher J Earley
Journal:  Sleep Med       Date:  2005-09-28       Impact factor: 3.492

9.  Prefrontal neuropsychological effects of sleep deprivation in young adults--a model for healthy aging?

Authors:  Y Harrison; J A Horne; A Rothwell
Journal:  Sleep       Date:  2000-12-15       Impact factor: 5.849

10.  Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome.

Authors:  Jens Carsten Möller; Yvonne Körner; Werner Cassel; Charlotte Meindorfner; Hans-Peter Krüger; Wolfgang H Oertel; Karin Stiasny-Kolster
Journal:  Sleep Med       Date:  2006-03-22       Impact factor: 3.492

View more
  21 in total

1.  Executive and Visuospatial Dysfunction in Patients With Primary Restless Legs Syndrome/Willis-Ekbom Disease: Study of a Chinese Population.

Authors:  Gen Li; Huidong Tang; Jie Chen; Xuemei Qi; Shengdi Chen; Jianfang Ma
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

Review 2.  Imaging brain functional and metabolic changes in restless legs syndrome.

Authors:  Giovanni Rizzo; Caterina Tonon; David Manners; Claudia Testa; Raffaele Lodi
Journal:  Curr Neurol Neurosci Rep       Date:  2013-09       Impact factor: 5.081

3.  Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep.

Authors:  Richard P Allen; Peter B Barker; Alena Horská; Christopher J Earley
Journal:  Neurology       Date:  2013-04-26       Impact factor: 9.910

4.  Sleep disturbances and nocturnal agitation behaviors in older adults with dementia.

Authors:  Karen M Rose; Cornelia Beck; Pao-Feng Tsai; Pham H Liem; David G Davila; Morton Kleban; Nalaka S Gooneratne; Gurpreet Kalra; Kathy Culpepper Richards
Journal:  Sleep       Date:  2011-06-01       Impact factor: 5.849

Review 5.  Brain imaging and networks in restless legs syndrome.

Authors:  Giovanni Rizzo; Xu Li; Sebastiano Galantucci; Massimo Filippi; Yong Won Cho
Journal:  Sleep Med       Date:  2016-08-29       Impact factor: 3.492

6.  Acute dopamine-agonist treatment in restless legs syndrome: effects on sleep architecture and NREM sleep instability.

Authors:  Raffaele Ferri; Mauro Manconi; Debora Aricò; Carolina Sagrada; Marco Zucconi; Oliviero Bruni; Alessandro Oldani; Luigi Ferini-Strambi
Journal:  Sleep       Date:  2010-06       Impact factor: 5.849

7.  Pramipexole alters thermoregulation in restless legs syndrome.

Authors:  Aaro V Salminen; Ville Rimpilä; Olli Polo
Journal:  J Clin Sleep Med       Date:  2014-12-15       Impact factor: 4.062

8.  No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome.

Authors:  Erika Driver-Dunckley; Donald Connor; Joe Hentz; Marwan Sabbagh; Nina Silverberg; Jose Hernandez; Linda Vedders; Virgilio Gerald Evidente; Holly Shill; John Caviness; Charles Adler
Journal:  Mov Disord       Date:  2009-09-15       Impact factor: 10.338

9.  Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.

Authors:  Sophie Bayard; Muriel Croisier Langenier; Yves Dauvilliers
Journal:  Sleep       Date:  2013-10-01       Impact factor: 5.849

10.  Neurocognitive consequences of sleep deprivation.

Authors:  Namni Goel; Hengyi Rao; Jeffrey S Durmer; David F Dinges
Journal:  Semin Neurol       Date:  2009-09-09       Impact factor: 3.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.